MULTICENTER, RANDOMIZED, PARALLEL-GROUP,DOUBLE-BLIND, PLACEBO-CONTROLLED (12-17 YEARS)INCLUDING A SINGLE OPEN-LABEL ARM (6-11 YEARS)STUDY TO EVALUATE THE EFFICACY, SAFETY, ANDPHARMACOKINETICS OF CERTOLIZUMAB PEGOL (CZP) INPEDIATRIC STUDY PARTICI

Project: Research project

Project Details

StatusActive
Effective start/end date5/17/20 → 8/31/50

Funding

  • Northwestern University
  • UCB Biosciences, Inc.